MADRIGAL PHARMACEUTICALS, INC. - Common Stock, $0.0001 par value per share (MDGL)

CUSIP: 558868105

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
22,822,754
Total 13F shares
23,552,943
Share change
-126,176
Total reported value
$7,127,866,991
Put/Call ratio
63%
Price per share
$302.64
Number of holders
303
Value change
-$58,976,553
Number of buys
142
Number of sells
161

Security key

558868105

Report period

Q2 2025

Institutions

303

Top holders

10

Top shareholders of MDGL - MADRIGAL PHARMACEUTICALS, INC. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
JANUS HENDERSON GROUP PLC
13F
Company
9.7%
2,205,849
$723,109,563 31 Mar 2025
13F
PAULSON & CO. INC.
13F
Company
9.2%
2,099,523
$695,425,003 31 Mar 2025
13F
Avoro Capital Advisors LLC
13F
Company
8.9%
2,022,222
$669,820,593 31 Mar 2025
13F
RTW INVESTMENTS, LP
13F
Company
8.7%
1,993,687
$660,368,945 31 Mar 2025
13F
BAKER BROS. ADVISORS LP
13F
Company
8.7%
1,974,590
$654,043,446 31 Mar 2025
13F
VANGUARD GROUP INC
13F
Company
7.4%
1,690,111
$559,815,467 31 Mar 2025
13F
BlackRock, Inc.
13F
Company
6.5%
1,486,460
$492,360,146 31 Mar 2025
13F
STATE STREET CORP
13F
Company
3.3%
758,511
$251,241,599 31 Mar 2025
13F
FMR LLC
13F
Company
2.9%
652,099
$215,994,634 31 Mar 2025
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
2.4%
542,633
$179,737,000 31 Mar 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1.8%
420,875
$139,437,103 31 Mar 2025
13F
Holocene Advisors, LP
13F
Company
1.7%
390,545
$129,360,220 31 Mar 2025
13F
MORGAN STANLEY
13F
Company
1.7%
384,828
$127,466,856 31 Mar 2025
13F
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC
13F
Company
1.5%
353,155
$116,975,531 31 Mar 2025
13F
UBS Group AG
13F
Company
1.4%
321,507
$106,492,763 31 Mar 2025
13F
Woodline Partners LP
13F
Company
1.4%
317,433
$105,143,333 31 Mar 2025
13F
BANK OF AMERICA CORP /DE/
13F
Company
1.1%
245,961
$81,469,497 31 Mar 2025
13F
Hood River Capital Management LLC
13F
Company
1.1%
243,994
$80,818,133 31 Mar 2025
13F
Pictet Asset Management Holding SA
13F
Company
0.91%
207,043
$68,501,351 31 Mar 2025
13F
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
0.84%
191,609
$63,466,649 31 Mar 2025
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.83%
189,639
$62,814,126 31 Mar 2025
13F
ArrowMark Colorado Holdings LLC
13F
Company
0.79%
180,109
$59,657,504 31 Mar 2025
13F
Rock Springs Capital Management LP
13F
Company
0.73%
166,698
$55,215,379 31 Mar 2025
13F
Erste Asset Management GmbH
13F
Company
0.72%
164,400
$54,372,228 31 Mar 2025
13F
AMERICAN CENTURY COMPANIES INC
13F
Company
0.69%
158,306
$52,435,995 31 Mar 2025
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.66%
151,251
$50,098,869 31 Mar 2025
13F
NORTHERN TRUST CORP
13F
Company
0.66%
150,886
$49,977,970 31 Mar 2025
13F
Polar Capital Holdings Plc
13F
Company
0.66%
150,220
$49,757,371 31 Mar 2025
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.63%
142,643
$47,247,641 31 Mar 2025
13F
Artisan Partners Limited Partnership
13F
Company
0.6%
137,738
$45,622,958 31 Mar 2025
13F
ARMISTICE CAPITAL, LLC
13F
Company
0.6%
135,883
$45,008,526 31 Mar 2025
13F
Invesco Ltd.
13F
Company
0.58%
132,934
$44,031,729 31 Mar 2025
13F
Fiera Capital Corp
13F
Company
0.58%
132,179
$43,781,651 31 Mar 2025
13F
LORD, ABBETT & CO. LLC
13F
Company
0.52%
118,024
$39,093,000 31 Mar 2025
13F
Tao Capital Management LP
13F
Company
0.49%
112,785
$37,357,776 31 Mar 2025
13F
Connor, Clark & Lunn Investment Management Ltd.
13F
Company
0.45%
102,360
$33,904,703 31 Mar 2025
13F
MPM BioImpact LLC
13F
Company
0.44%
100,415
$33,260,460 31 Mar 2025
13F
D. E. Shaw & Co., Inc.
13F
Company
0.43%
99,006
$32,793,757 31 Mar 2025
13F
NORGES BANK
13F
Company
0.41%
93,997
$31,134,626 31 Mar 2025
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.37%
85,086
$28,183,036 31 Mar 2025
13F
Affinity Asset Advisors, LLC
13F
Company
0.35%
80,000
$26,498,400 31 Mar 2025
13F
EcoR1 Capital, LLC
13F
Company
0.33%
75,000
$24,842,250 31 Mar 2025
13F
Mirae Asset Global Investments Co., Ltd.
13F
Company
0.31%
70,341
$23,289,698 31 Mar 2025
13F
VICTORY CAPITAL MANAGEMENT INC
13F
Company
0.3%
68,390
$22,652,820 31 Mar 2025
13F
Soleus Capital Management, L.P.
13F
Company
0.3%
67,500
$22,358,025 31 Mar 2025
13F
Point72 Asset Management, L.P.
13F
Company
0.29%
65,860
$21,814,807 31 Mar 2025
13F
Bank of New York Mellon Corp
13F
Company
0.27%
60,789
$20,135,092 31 Mar 2025
13F
FEDERATED HERMES, INC.
13F
Company
0.25%
58,025
$19,219,621 31 Mar 2025
13F
RAYMOND JAMES FINANCIAL INC
13F
Company
0.24%
53,916
$17,858,590 31 Mar 2025
13F
JANE STREET GROUP, LLC
13F
Company
0.23%
51,890
$17,187,525 31 Mar 2025
13F

Institutional Holders of MADRIGAL PHARMACEUTICALS, INC. - Common Stock, $0.0001 par value per share (MDGL) as of Q2 2025

As of 30 Jun 2025, MADRIGAL PHARMACEUTICALS, INC. - Common Stock, $0.0001 par value per share (MDGL) was held by 303 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 23,552,943 shares. The largest 10 holders included JANUS HENDERSON GROUP PLC, PAULSON & CO. INC., RTW INVESTMENTS, LP, BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, Avoro Capital Advisors LLC, BlackRock, Inc., STATE STREET CORP, PRICE T ROWE ASSOCIATES INC /MD/, and UBS Group AG. This page lists 305 institutional shareholders reporting positions in this security for the Q2 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders
317
Q2 2025 holders
303
Holder diff
-14
Investor Q1 2025 Shares Q2 2025 Shares Share Diff Share Chg % Q1 2025 Value $ Q2 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .